… and enterococcal isolates from infections in patients housed in … Pseudomonas aeruginosa
and Acinetobacter baumannii have developed resistance to multiple antimicrobial agents …

… of Pseudomonas aeruginosa isolates to these same antibiotics … cost of developing a new
antibacterial agent is not justified by the … due to multidrug-resistant Acinetobacter baumannii …

… discusses the major challenging issues for their management. … Finding suitable antimicrobial
treatment options for MDR A. … Pseudomonas aeruginosa and Acinetobacter baumannii. …

… but not in Enterobacteriaceae or in Pseudomonas aeruginosa (… baumannii has been identified
and characterized as a … these agents in the treatment of serious Acinetobacter infections …

… , Acinetobacter baumannii, Pseudomonas aeruginosa, and … baumannii infections, there is
mounting pressure to find new … While A.baumannii remains a major public health challenge …

… to antimicrobial drugs currently used for the treatment of … baumannii; however, Spanish
researchers have identified … Considering the issues presented previously, we will further discuss …

… in CRAB infections, including BSI, did not find evidence for … therapy mainly against
Pseudomonas aeruginosa rather than … ) for the treatment of bacterial infections is challenging due …

… It is intrinsically resistant to many antimicrobial agents and additional acquired … to
ceftolozane-tazobactam has been identified in P. … aeruginosa, in challenging clinical situations …

… points of attack of antibiotic agents comprising the inhibition of … of antimicrobial peptides
have been identified and deposited … , circumventing transport issues of potential drugs with the …

… These findings identify ZY4 as an ideal candidate against … for new antimicrobial drugs, only
a few new viable antibiotics … Development of resistance is a great challenge that hampers …